Early immunization with inactivated poliovirus vaccine in premature infants

Area of Science:

• Pediatrics
• Immunology
• Vaccinology

Background:

• Premature infants often have delayed or suboptimal immune responses to standard vaccination schedules.
• Polio remains a global public health concern, necessitating effective vaccination strategies.

Purpose of the Study:

• To evaluate the immunogenicity of an early inactivated poliovirus vaccine (IPV) dose in premature infants.
• To compare antibody titers in premature infants receiving an early IPV dose versus a standard schedule.

Main Methods:

• A comparative study involving two groups of premature infants.
• One group received an additional IPV dose at 5-10 days of age (study group).
• The control group received IPV at 2 months of age, with antibody titers measured at 1 month.

Main Results:

• 97.4% of the study group had protective antibodies against poliovirus 3 at 1 month.
• Only 70.8% of the control group achieved protective titers against poliovirus 3 at 1 month.
• The difference in protective antibody rates was statistically significant (p < 0.001).

Conclusions:

• An early IPV dose administered 5-10 days after birth enhances early protection against poliovirus 3 in premature infants.
• This early vaccination strategy appears more effective in achieving protective antibody levels sooner than the standard schedule.
• Further research may support optimizing IPV schedules for vulnerable premature infant populations.